Vnitr̆ní lékar̆ství
-
Vnitr̆ní lékar̆ství · Mar 2011
Review[Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].
Most patients treated with statins die due to cardiovascular events. The risk of cardiovascular event during statin treatment is called residual risk. ⋯ Residual risk can be decreased by combination therapy statins with fibrates or statins with niacin; niacin can affect almost all lipids and lipoproteins that participate in residual risk. There are evidences from clinical trials that combinations statin with fibrates or statin with niacin are safe.